A Phase 1, Open-Label, Single-Dose, Mass Balance Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]-LC350189 in Healthy Male Subjects
Latest Information Update: 29 Jun 2020
At a glance
- Drugs Tigulixostat (Primary)
- Indications Gout; Hyperuricaemia
- Focus Pharmacokinetics
- Sponsors LG Chem
Most Recent Events
- 24 Jun 2020 Status changed from not yet recruiting to completed.
- 03 Sep 2019 New trial record